AEON Biopharma's total assets for Q3 2024 were $4.00M, a decrease of -30.17% from the previous quarter. AEON total liabilities were $36.09M for the fiscal quarter, a 7.16% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.